Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Atyeo

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Biorxiv : the Preprint Server for Biology|February 10, 2021
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccinationMatthew J Gorman, Nita Patel, Mimi Guebre-Xabier, et al.
Nature|June 9, 2021
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humansGalit Alter, Jingyou Yu, Jinyan Liu, et al.
Database : the Journal of Biological Databases and Curation|February 10, 2023
Coronavirus Immunotherapeutic Consortium DatabaseJarjapu Mahita, Brendan Ha, Anais Gambiez, et al.
Medrxiv : the Preprint Server for Health Sciences|November 17, 2020
Epidemiological and immunological features of obesity and SARS-CoV-2Eric J Nilles, Sameed M Siddiqui, Stephanie Fischinger, et al.
Cell Chemical Biology|August 16, 2023
Multimodal, broadly neutralizing antibodies against SARS-CoV-2 identified by high-throughput native pairing of BCRs from bulk B cellsGladys J Keitany, Benjamin E R Rubin, Meghan E Garrett, et al.
Nature Communications|February 16, 2021
Discrete SARS-CoV-2 antibody titers track with functional humoral stabilityYannic C Bartsch, Stephanie Fischinger, Sameed M Siddiqui, et al.
Mbio|January 25, 2022
Serological Markers of SARS-CoV-2 ReinfectionSameed M Siddiqui, Kathryn A Bowman, Alex L Zhu, et al.
Cell Reports. Medicine|September 6, 2021
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccinationMatthew J Gorman, Nita Patel, Mimi Guebre-Xabier, et al.
Immunity|February 25, 2021
A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungsNanda Kishore Routhu, Narayanaiah Cheedarla, Sailaja Gangadhara, et al.
The Journal of Infectious Diseases|October 31, 2022
SARS-CoV-2 Serosurveys: How Antigen, Isotype and Threshold Choices Affect the OutcomeRaquel A Binder, Gavin F Fujimori, Catherine S Forconi, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Biorxiv : the Preprint Server for Biology|February 10, 2021
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccinationMatthew J Gorman, Nita Patel, Mimi Guebre-Xabier, et al.
Nature|June 9, 2021
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humansGalit Alter, Jingyou Yu, Jinyan Liu, et al.
Database : the Journal of Biological Databases and Curation|February 10, 2023
Coronavirus Immunotherapeutic Consortium DatabaseJarjapu Mahita, Brendan Ha, Anais Gambiez, et al.
Medrxiv : the Preprint Server for Health Sciences|November 17, 2020
Epidemiological and immunological features of obesity and SARS-CoV-2Eric J Nilles, Sameed M Siddiqui, Stephanie Fischinger, et al.
Cell Chemical Biology|August 16, 2023
Multimodal, broadly neutralizing antibodies against SARS-CoV-2 identified by high-throughput native pairing of BCRs from bulk B cellsGladys J Keitany, Benjamin E R Rubin, Meghan E Garrett, et al.
Nature Communications|February 16, 2021
Discrete SARS-CoV-2 antibody titers track with functional humoral stabilityYannic C Bartsch, Stephanie Fischinger, Sameed M Siddiqui, et al.
Mbio|January 25, 2022
Serological Markers of SARS-CoV-2 ReinfectionSameed M Siddiqui, Kathryn A Bowman, Alex L Zhu, et al.
Cell Reports. Medicine|September 6, 2021
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccinationMatthew J Gorman, Nita Patel, Mimi Guebre-Xabier, et al.
Immunity|February 25, 2021
A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungsNanda Kishore Routhu, Narayanaiah Cheedarla, Sailaja Gangadhara, et al.
The Journal of Infectious Diseases|October 31, 2022
SARS-CoV-2 Serosurveys: How Antigen, Isotype and Threshold Choices Affect the OutcomeRaquel A Binder, Gavin F Fujimori, Catherine S Forconi, et al.
Pageof 8